Concepts (91)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cancer Pain | 5 | 2020 | 312 | 0.950 |
Why?
|
| Injections, Spinal | 4 | 2020 | 257 | 0.840 |
Why?
|
| omega-Conotoxins | 1 | 2020 | 7 | 0.790 |
Why?
|
| Receptors, GABA-B | 2 | 2012 | 33 | 0.700 |
Why?
|
| Analgesics, Non-Narcotic | 1 | 2020 | 126 | 0.690 |
Why?
|
| Posterior Horn Cells | 2 | 2012 | 125 | 0.650 |
Why?
|
| Ganglia, Spinal | 2 | 2012 | 237 | 0.630 |
Why?
|
| Spinal Nerves | 2 | 2012 | 45 | 0.530 |
Why?
|
| Pain Management | 3 | 2018 | 668 | 0.510 |
Why?
|
| Spinal Cord Stimulation | 1 | 2013 | 27 | 0.450 |
Why?
|
| Fentanyl | 1 | 2014 | 148 | 0.440 |
Why?
|
| Visceral Pain | 1 | 2012 | 9 | 0.440 |
Why?
|
| Reflex | 1 | 2012 | 68 | 0.430 |
Why?
|
| Oxytocin | 1 | 2012 | 62 | 0.430 |
Why?
|
| Neurons, Afferent | 1 | 2012 | 122 | 0.410 |
Why?
|
| Drug Delivery Systems | 2 | 2014 | 669 | 0.350 |
Why?
|
| Urinary Bladder | 1 | 2012 | 575 | 0.350 |
Why?
|
| Cross Infection | 1 | 2013 | 544 | 0.320 |
Why?
|
| Analgesics, Opioid | 2 | 2018 | 1371 | 0.320 |
Why?
|
| Peripheral Nervous System Diseases | 2 | 2017 | 393 | 0.320 |
Why?
|
| Neuralgia | 2 | 2012 | 251 | 0.300 |
Why?
|
| Splanchnic Nerves | 2 | 2016 | 13 | 0.290 |
Why?
|
| Pain | 2 | 2016 | 1658 | 0.270 |
Why?
|
| Peripheral Nerve Injuries | 1 | 2006 | 60 | 0.270 |
Why?
|
| Peripheral Nerves | 1 | 2006 | 159 | 0.260 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2012 | 2063 | 0.200 |
Why?
|
| Neoplasms | 4 | 2020 | 15193 | 0.170 |
Why?
|
| Ligation | 2 | 2012 | 193 | 0.170 |
Why?
|
| Substance Abuse Detection | 1 | 2018 | 64 | 0.160 |
Why?
|
| Pain Clinics | 2 | 2018 | 17 | 0.160 |
Why?
|
| Rats | 3 | 2012 | 6086 | 0.150 |
Why?
|
| Celiac Plexus | 1 | 2016 | 13 | 0.140 |
Why?
|
| Autonomic Nerve Block | 1 | 2016 | 12 | 0.140 |
Why?
|
| Phenol | 1 | 2016 | 19 | 0.140 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2014 | 5319 | 0.140 |
Why?
|
| Lumbosacral Region | 2 | 2014 | 49 | 0.140 |
Why?
|
| Angiotensin Receptor Antagonists | 1 | 2017 | 151 | 0.140 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2017 | 257 | 0.130 |
Why?
|
| Blood Patch, Epidural | 1 | 2014 | 7 | 0.120 |
Why?
|
| Post-Dural Puncture Headache | 1 | 2014 | 5 | 0.120 |
Why?
|
| Hematoma, Epidural, Spinal | 1 | 2014 | 16 | 0.120 |
Why?
|
| Ethanol | 1 | 2016 | 264 | 0.120 |
Why?
|
| Intraoperative Period | 1 | 2014 | 246 | 0.120 |
Why?
|
| Medication Adherence | 1 | 2018 | 492 | 0.110 |
Why?
|
| Subarachnoid Hemorrhage | 1 | 2014 | 95 | 0.110 |
Why?
|
| Abdominal Pain | 1 | 2016 | 369 | 0.110 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 2012 | 189 | 0.110 |
Why?
|
| Lung Neoplasms | 1 | 2014 | 11538 | 0.100 |
Why?
|
| Microscopy, Confocal | 1 | 2012 | 663 | 0.090 |
Why?
|
| Action Potentials | 1 | 2012 | 560 | 0.090 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2017 | 2594 | 0.080 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2012 | 1217 | 0.080 |
Why?
|
| Male | 9 | 2018 | 123000 | 0.070 |
Why?
|
| Retrospective Studies | 5 | 2018 | 37905 | 0.070 |
Why?
|
| Guanosine 5'-O-(3-Thiotriphosphate) | 1 | 2006 | 38 | 0.070 |
Why?
|
| GABA Agonists | 1 | 2006 | 23 | 0.070 |
Why?
|
| Baclofen | 1 | 2006 | 42 | 0.070 |
Why?
|
| Denervation | 1 | 2006 | 33 | 0.070 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2014 | 4938 | 0.070 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2012 | 3639 | 0.070 |
Why?
|
| Presynaptic Terminals | 1 | 2006 | 114 | 0.070 |
Why?
|
| Proportional Hazards Models | 1 | 2014 | 4988 | 0.070 |
Why?
|
| Neural Inhibition | 1 | 2006 | 147 | 0.060 |
Why?
|
| Protein Subunits | 1 | 2006 | 274 | 0.060 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2006 | 269 | 0.060 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2014 | 6207 | 0.060 |
Why?
|
| Hyperalgesia | 1 | 2006 | 238 | 0.060 |
Why?
|
| Middle Aged | 6 | 2018 | 86204 | 0.060 |
Why?
|
| Female | 7 | 2018 | 141928 | 0.060 |
Why?
|
| Synaptic Transmission | 1 | 2006 | 443 | 0.050 |
Why?
|
| Disease-Free Survival | 1 | 2014 | 10001 | 0.050 |
Why?
|
| Humans | 9 | 2020 | 261506 | 0.050 |
Why?
|
| Animals | 3 | 2012 | 59536 | 0.050 |
Why?
|
| Immunohistochemistry | 1 | 2012 | 7548 | 0.050 |
Why?
|
| Up-Regulation | 1 | 2006 | 2450 | 0.040 |
Why?
|
| Touch | 1 | 2017 | 71 | 0.040 |
Why?
|
| Pain Threshold | 1 | 2017 | 130 | 0.040 |
Why?
|
| Receptor, Angiotensin, Type 2 | 1 | 2017 | 46 | 0.040 |
Why?
|
| Self Report | 1 | 2018 | 756 | 0.030 |
Why?
|
| Nerve Block | 1 | 2016 | 176 | 0.030 |
Why?
|
| Antineoplastic Agents | 1 | 2017 | 14289 | 0.030 |
Why?
|
| Tinnitus | 1 | 2014 | 38 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2006 | 7222 | 0.030 |
Why?
|
| Pain Measurement | 1 | 2016 | 953 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2013 | 32848 | 0.030 |
Why?
|
| Adult | 3 | 2018 | 77950 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2018 | 9244 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2018 | 14889 | 0.010 |
Why?
|
| Aged | 2 | 2017 | 70117 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 2014 | 5542 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2017 | 29902 | 0.010 |
Why?
|